Celldex Therapeutics to Present at Upcoming Investor Conferences
March 04 2025 - 7:01AM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
management will participate in fireside chats at two upcoming
conferences:
TD Cowen 45th Annual Health Care Conference on
Tuesday, March 4th at 1:50 p.m. ET
Leerink Partners Global Healthcare Conference on
Tuesday, March 11th at 1:00 p.m. ET
Live webcasts of the presentations will be
available on the "Events & Presentations” page of the
"Investors & Media" section of the Celldex website. Replays
will be available for 90 days following the event.
About Celldex Therapeutics,
Inc.Celldex is a clinical stage biotechnology company
leading the science at the intersection of mast cell biology and
the development of transformative therapeutics for patients. Our
pipeline includes antibody-based therapeutics which have the
ability to engage the human immune system and/or directly affect
critical pathways to improve the lives of patients with severe
inflammatory, allergic, autoimmune and other devastating diseases.
Visit www.celldex.com.
Company ContactSarah
CavanaughSenior Vice President, Corporate Affairs &
Administration(508) 864-8337scavanaugh@celldex.com
Patrick TillMeru Advisors(484)
788-8560ptill@meruadvisors.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Feb 2025 to Mar 2025
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2024 to Mar 2025